TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Antiretroviral therapy for prevention of HIV and TB: A promising intervention but not a panacea

Aspiration for TasP should not distract attention from the quality of HIV programming, the effectiveness of the HIV care cascade, and the need for inclusion of other HIV prevention interventions and other TB prevention measures.

Read More →

The “worst public health epidemic we’re facing today”? Tuberculosis in the mining sector

A third of all new cases of TB in Africa are thought to be related to the mining industry.

Read More →

EECA CAB position statements on Janssen, Gilead and Pharmasyntez

The position statements focus on the drugs for treating HIV (Janssen, Gilead, Pharmasyntez), HCV (Janssen, Gilead) and TB (Janssen, Pharmasyntez).

Read More →

MSF: India must address worrying stock out of tuberculosis drugs

Indian government drug tender process leads to deadly delay in drug supply.

Read More →

WHO interim guidance on the use of bedaquiline to treat MDR-TB

The interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the programmatic management of drug-resistant TB (2011 Update).

Read More →

Announcing new resource for M/XDR-TB, TB/HIV and pediatric TB treatment advice: ERS-WHO E-Consilium

The ERS and WHO will now provide scientifically sound and evidence-based advice, and clinical consultation through the Internet to national consiliums and individual practitioners on the management of MDR-TB and other difficult-to-treat TB cases, including TB/HIV and paediatric cases.

Read More →

TBVI, Aeras: TB vaccine business case: lifesaving TB vaccines feasible

Making new TB vaccines available to the world over the next 10-15 years is estimated to cost approximately €600 million, utilizing a highly efficient portfolio approach and adequate funding.

Read More →

Shortages of drugs threaten TB fight

The U.S., India and other nations are facing shortages of tuberculosis drugs - threatening to reverse decades of progress against a deadly disease that is becoming increasingly untreatable.

Read More →

Civil society groups urge Qiagen to look into misuse of TB Gold kit

Based on the survey report findings, the Treatment Action Group and Global TB Community Advisory Board and other civil society members have found that Indian doctors are replacing the banned serological tests with Qiagen’s QuantiFERON-TB Gold.

Read More →

Launch of EECA CAB website

Now Eastern European and Central Asian Community Advisory Board (EECA CAB), a joint initiative of ITPCru and ECUO, has a website: www.eeca-cab.org/en.

Read More →

Page 110 of 133 · Total posts: 10

←First 109 110 111 Last→